Real‐world genetic testing outcomes of pan‐cancer testing for mismatch repair deficiency
Teresa S. Chai(Massachusetts General Hospital), Daniel C. Chung(Massachusetts General Hospital), Anthony R. Mattia(Maine Medical Center), Linda Rodgers(Massachusetts General Hospital), Jenna O. Walls(Massachusetts General Hospital)
Cited by 2
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k
The Chromosomal Instability Pathway in Colon Cancer
|Gastroenterology|2010|932